Clinical Trial Update: Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of Voxilaprevir plus Sofosbuvir/Velpatasvir fixed-dose combination in adults with chronic non-genotype 1 hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir Fixed Dose Combination (sofosbuvir/velpatasvir)
• voxilaprevir (voxilaprevir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-09-15